Creating Health Course Study for People With Rheumatological Conditions
Part of paid clinical trials in Iowa City, Iowa.
- Sponsor
- Terry L. Wahls
- Study ID
- NCT07180537
- Status
- Recruiting
Conditions
- Mixed Connective Tissue Disease
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Sjogren's Syndrome
- Systemic Lupus Erythematosus
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- Creating Health Online Course — BEHAVIORALImmediate access to an online audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care
- Delayed access to Creating Health Online Course — BEHAVIORALDelayed access (12-week delay) to an online audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care
Study Details
The goal of this project is to critically evaluate the effectiveness of an online health program designed to improve diet and self-care in patients with rheumatological conditions, including rheumatoid arthritis (RA), Sjogren's syndrome (SS), systemic lupus erythematosus (SLE), mixed connective tissue disease (MCTD), psoriatic arthritis (PsA), Additionally, investigators will assess the program's effectiveness, as well as the challenges and facilitators involved in using an online wellness program to reduce fatigue and enhance the quality of life in patients suffering from these conditions.
Key Dates
- Start date
- Dec 1, 2025
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Immediate Intervention: Creating Health Online courseThis arm will begin the intervention immediately after randomization
- Other: Delayed Intervention: Creating Health Online courseThis is the control arm.
Primary Outcome Measure
Modified Fatigue Impact Scale (MFIS) [ Time Frame: Day 0 to Month 3 ]
Central Contacts
- Study Coordinator319 384 5002
- Mary Ehlinger, BS319 384 5002
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Univeristy of Iowa | Iowa City | Iowa | 52246 | Terry Wahls, MD (PRINCIPAL_INVESTIGATOR) Linda Snetselaar, PhD, RD (SUB_INVESTIGATOR) |
Find similar trials in Iowa City, IA
By research site
Related Studies
- A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusPHASE3 · Recruiting · UCB Biopharma SRL · Avondale, Arizona
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.PHASE1 · Recruiting · AstraZeneca · Anniston, Alabama
- A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)PHASE1 · Not Yet Recruiting · Genentech, Inc. · Birmingham, Alabama
- Study of Systemic Lupus ErythematosusRecruiting · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Bethesda, Maryland